These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 16336012)
1. Comment on "The economics of follow-on drug research and development: trends in entry rates and the timing of development". Hollis A Pharmacoeconomics; 2005; 23(12):1187-92; discussion 1193-202. PubMed ID: 16336012 [No Abstract] [Full Text] [Related]
2. The economics of follow-on drug research and development: trends in entry rates and the timing of development. DiMasi JA; Paquette C Pharmacoeconomics; 2004; 22(2 Suppl 2):1-14. PubMed ID: 15660473 [TBL] [Abstract][Full Text] [Related]
3. Are the economics of pharmaceutical research and development changing?: productivity, patents and political pressures. Grabowski H Pharmacoeconomics; 2004; 22(2 Suppl 2):15-24. PubMed ID: 15660474 [TBL] [Abstract][Full Text] [Related]
4. Biotechnology's metamorphosis into a drug discovery industry. Drews J Nat Biotechnol; 1998 May; 16 Suppl():22-4. PubMed ID: 9591258 [No Abstract] [Full Text] [Related]
5. Antibacterial drug discovery: is small pharma the solution? Boggs AF; Miller GH Clin Microbiol Infect; 2004 Nov; 10 Suppl 4():32-6. PubMed ID: 15522038 [TBL] [Abstract][Full Text] [Related]
6. Drug Discovery Technology and Development 2005 - IBC's Tenth World Congress. Emerging and early stage company showcase pre-conference symposium. Razvi ES IDrugs; 2005 Oct; 8(10):796-8. PubMed ID: 16254794 [No Abstract] [Full Text] [Related]
7. In biomarkers we trust? Baker M Nat Biotechnol; 2005 Mar; 23(3):297-304. PubMed ID: 15765081 [No Abstract] [Full Text] [Related]
8. Venturing into drug discovery. Steinmetz M Nat Biotechnol; 1998 May; 16 Suppl():17. PubMed ID: 9591255 [No Abstract] [Full Text] [Related]
9. Pharmaceutical research: cost savings through innovation. Cohen KR; Levy RA AAPPO J; 1993 Oct; 3(5):28-36. PubMed ID: 10146463 [No Abstract] [Full Text] [Related]
10. Deal watch: Trends in platform technology deal-making. Walker J; Jacob J Nat Rev Drug Discov; 2009 Dec; 8(12):923. PubMed ID: 19949395 [No Abstract] [Full Text] [Related]
11. New economics of the pharmaceutical supply chain. Yost RD Am J Health Syst Pharm; 2005 Mar; 62(5):525-6. PubMed ID: 15745917 [No Abstract] [Full Text] [Related]
12. The power of genomics to transform the biotechnology industry. Haseltine WA Nat Biotechnol; 1998 May; 16 Suppl():25-7. PubMed ID: 9591259 [No Abstract] [Full Text] [Related]
13. Lessons from 54 years of pharmaceutical research. Firestone RA Nat Rev Drug Discov; 2011 Oct; 10(12):963. PubMed ID: 22036986 [No Abstract] [Full Text] [Related]
14. Drug discovery alliances. Jones A; Clifford L Nat Rev Drug Discov; 2005 Oct; 4(10):807-8. PubMed ID: 16237845 [No Abstract] [Full Text] [Related]
15. Trendspotting: betting strong but playing safe. Anderegg MH; Thayer JM; Williams KM Nat Biotechnol; 2006 Jul; 24(7):741-3. PubMed ID: 16924774 [TBL] [Abstract][Full Text] [Related]
16. Carlo Incerti. Incerti C Nat Rev Drug Discov; 2008 Aug; 7(8):638. PubMed ID: 18670428 [No Abstract] [Full Text] [Related]
18. Streamlining drug discovery: finding the right drug against the right target to treat the right disease. Ng JH; Ilag LL Drug Discov Today; 2004 Jan; 9(2):59-60. PubMed ID: 15025066 [No Abstract] [Full Text] [Related]
19. Surviving the blockbuster syndrome. Service RF Science; 2004 Mar; 303(5665):1796-9. PubMed ID: 15031490 [No Abstract] [Full Text] [Related]
20. Trends in the development of chiral drugs. Caner H; Groner E; Levy L; Agranat I Drug Discov Today; 2004 Feb; 9(3):105-10. PubMed ID: 15038394 [No Abstract] [Full Text] [Related] [Next] [New Search]